Department of Paediatrics and Adolescent Medicine

Medicine & Life Sciences

1. Child 100%
2. Precursor Cell Lymphoblastic Leukemia-Lymphoma 73%
3. Pediatrics 63%
4. Denmark 47%
5. Cystic Fibrosis 39%
6. Ciliary Motility Disorders 35%
7. Cohort Studies 31%
8. Hematopoietic Stem Cell Transplantation 26%
9. Therapeutics 26%
10. Neoplasms 25%
11. Lung 19%
12. Population 18%
13. Young Adult 17%
14. Juvenile Arthritis 16%
15. Confidence Intervals 16%
16. Randomized Controlled Trials 16%
17. Infections 15%
18. Mercaptopurine 15%
19. Parents 15%
20. Recurrence 15%
21. Parturition 15%
22. Vaccination 15%
23. Cerebral Palsy 14%
24. Asparaginase 14%
25. Mutation 14%
26. Acute Myeloid Leukemia 14%
27. Registries 13%
28. Newborn Infant 12%
29. Phenotype 12%
30. Incidence 12%
31. Leukemia 11%
32. Survival 11%
33. Epilepsy 11%
34. Survivors 11%
35. Premature Infants 11%
36. Exercise 10%
37. Hematology 10%
38. Methotrexate 10%
39. Mortality 10%
40. Wilms Tumor 10%
41. Systematic Reviews 10%
42. Residual Neoplasm 9%
43. Mothers 9%
44. Swine 9%
45. Hospitalization 9%
46. Cancer Survivors 9%
47. Genes 9%
48. Drug Therapy 8%
49. Thioguanine 8%
50. Scandinavian and Nordic Countries 8%
51. Colostrum 8%
52. Necrotizing Enterocolitis 8%
53. Pseudomonas aeruginosa 8%
54. Allogeneic Cells 8%
55. Meta-Analysis 7%
56. thiopurine methyltransferase 7%
57. Asthma 7%
58. Gestational Age 7%
59. Guidelines 7%
60. Respiratory Syncytial Viruses 7%
61. Quality of Life 7%
62. Pregnancy 7%
63. Genotype 7%
64. Odds Ratio 7%
65. alpha-Mannosidosis 7%
66. Placebos 7%
67. Inflammation 7%
68. Anti-Bacterial Agents 7%
69. Growth 6%
70. Chronic Disease 6%
71. Health 6%
72. Rett Syndrome 6%
73. Multicenter Studies 6%
74. Siblings 6%
75. Seizures 6%
76. Milk 6%
77. Stem Cell Transplantation 6%
78. Lung Diseases 6%
79. Central Nervous System Neoplasms 6%
80. Serum 6%
81. Morbidity 6%
82. Type 1 Diabetes Mellitus 6%
83. Brain Neoplasms 6%
84. Biomarkers 6%
85. Cell Transplantation 6%
86. pegaspargase 6%
87. Delivery of Health Care 5%
88. Antibodies 5%
89. Weights and Measures 5%
90. Heart Diseases 5%
91. Proteins 5%
92. Progression-Free Survival 5%
93. Intellectual Disability 5%
94. Clinical Trials 5%
95. Central Nervous System 5%
96. Transplants 5%
97. Cross-Sectional Studies 5%
98. Cattle 5%
99. Safety 5%
100. Bacillus 5%